000782149 000__ 04938cam\a2200517Ii\4500
000782149 001__ 782149
000782149 005__ 20230306143239.0
000782149 006__ m\\\\\o\\d\\\\\\\\
000782149 007__ cr\cn\nnnunnun
000782149 008__ 170516s2017\\\\sz\a\\\\o\\\\\000\0\eng\d
000782149 019__ $$a987341960
000782149 020__ $$a9783319524856$$q(electronic book)
000782149 020__ $$a3319524852$$q(electronic book)
000782149 020__ $$z9783319524849
000782149 020__ $$z3319524844
000782149 035__ $$aSP(OCoLC)ocn987302309
000782149 035__ $$aSP(OCoLC)987302309$$z(OCoLC)987341960
000782149 040__ $$aN$T$$beng$$erda$$epn$$cN$T$$dGW5XE$$dEBLCP$$dOCLCO$$dYDX$$dN$T$$dOCLCF$$dUAB
000782149 049__ $$aISEA
000782149 050_4 $$aRC114.5
000782149 08204 $$a616.9/1$$223
000782149 24500 $$aEmerging and re-emerging viral infections :$$badvances in microbiology, infectious diseases and public health.$$nVolume 6 /$$cedited by Giovanni Rezza, Giuseppe Ippolito.
000782149 264_1 $$aCham, Switzerland :$$bSpringer,$$c2017.
000782149 300__ $$a1 online resource (vi, 148 pages) :$$bcolor illustrations.
000782149 336__ $$atext$$btxt$$2rdacontent
000782149 337__ $$acomputer$$bc$$2rdamedia
000782149 338__ $$aonline resource$$bcr$$2rdacarrier
000782149 4901_ $$aAdvances in experimental medicine and biology, Advances in microbiology, infectious diseases and public health,$$x0065-2598 ;$$vvolume 972
000782149 500__ $$aIncludes index.
000782149 5050_ $$aPreface -- Emerging Viruses: From Early Detection to Intervention; References; How to Tackle Natural Focal Infections: From Risk Assessment to Vaccination Strategies; 1 Eco-Epidemiology: How to Predict and Control the Occurrence of Natural Focal Infectious Diseases; 1.1 Ecological Niche Modelling; 1.2 The Boosted Regression Trees Method; 1.3 Macroecology; 2 Natural Focal Diseases Mapping and Control: Two Paradigmatic Examples; 2.1 Crimean-Congo Hemorrhagic Fever: A Mapping Exercise; 2.2 A Vaccine for CCHF: Give Prevention a Chance
000782149 5058_ $$a2.3 Tick Borne Encephalitis: Vaccine Use to Control a Natural Focal Disease3 Conclusions; References; Human-Animal Interface: The Case for Influenza Interspecies Transmission; 1 Introduction; 2 The Viruses; 3 Molecular Determinants of Host-Range Restriction and Pathogenesis; 3.1 Hemagglutinin and Receptor-Binding Specificity; 3.2 Other Virulence Determinants; 4 Pandemic Influenza; 5 Animal Influenza; 5.1 Wild Bird-Domestic Bird Interface; 5.2 Domestic Bird-Mammalian Interface; 5.2.1 Domestic Poultry; 5.2.2 Swine Influenza; 6 Increasing Threats of Influenza at the Human-Animal Interface
000782149 5058_ $$aChanging Conditions that Favor Influenza Transmissibility7 Conclusions; References; Bats and Emerging Infections: An Ecological and Virological Puzzle; 1 Introduction; 2 Why the Bats Are Good Virus Reservoirs?; 2.1 Evolution and Phylogeny of Bats; 2.2 Species Richness; 2.3 Ability to Fly; 2.4 Long Lifespan and Bat Ecology; 3 Virus Dynamic in Bat Populations; 4 Changes in Ecology and Management of Bat Populations; 5 Risk Factors and Prevention Tasks; References; The Middle East Respiratory Syndrome Coronavirus -- A Continuing Risk to Global Health Security; 1 Introduction
000782149 5058_ $$a2 Epidemiological Features of MERS-CoV2.1 Discovery and Evolution; 2.2 Geographical Distribution; 2.3 Origin and Transmission of MERS-CoV; 2.4 Natural History and Pathogenesis; 3 Clinical Presentation; 4 Laboratory Diagnosis and Diagnostics; 5 Management of Mers Patients; 6 Infection Control and Transmission Risk; 7 Surveillance, Prevention and Control; References; Emerging Zika Virus Infection: A Rapidly Evolving Situation; 1 Introduction; 2 Geographic Distribution; 3 ZIKA Virus as Health Emergency of International Concern; 4 Phylogenesis; 5 Vectors and Reservoirs; 6 Flavivirus Structure
000782149 5058_ $$a7 Mode of Transmission7.1 Mosquitoe-Borne ZIKV Transmission; 7.2 Sexual ZIKV Transmission; 7.3 Blood Transfusion and Transplantation ZIKV Transmission; 7.4 Vertical ZIKV Transmission; 7.5 Human-To-Human ZIKV Transmission; 8 Clinical Manifestations; 8.1 Typical ZIKV Manifestation; 8.2 ZIKV-Associated Guillain-Barré Syndrome; 8.3 ZIKV-Associated Neurological Disorders; 8.4 ZIKV-Associated Microcephaly; 9 Diagnosis; 10 Biological Basis for Pathogenetic Effects; 11 Perspective for ZIKV Control and Treatment; 11.1 Vector Control; 11.2 Vaccine Development; 11.3 Therapeutics; 12 Conclusions
000782149 506__ $$aAccess limited to authorized users.
000782149 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed May 22, 2017).
000782149 650_0 $$aVirus diseases.
000782149 650_0 $$aEmerging infectious diseases.
000782149 7001_ $$aRezza, Giovanni,$$eeditor.
000782149 7001_ $$aIppolito, Giuseppe,$$eeditor.
000782149 77608 $$iPrint version:$$z3319524844$$z9783319524849$$w(OCoLC)966563666
000782149 830_0 $$aAdvances in experimental medicine and biology.$$pAdvances in microbiology, infectious diseases and public health ;$$vv. 972.
000782149 852__ $$bebk
000782149 85640 $$3SpringerLink$$uhttps://univsouthin.idm.oclc.org/login?url=http://link.springer.com/10.1007/978-3-319-52485-6$$zOnline Access$$91397441.1
000782149 909CO $$ooai:library.usi.edu:782149$$pGLOBAL_SET
000782149 980__ $$aEBOOK
000782149 980__ $$aBIB
000782149 982__ $$aEbook
000782149 983__ $$aOnline
000782149 994__ $$a92$$bISE